Baby Powder Lawyer Calls For Ban On Talc Products
Johnson & Johnson's baby powder attorney Ted Meadows claims that the medical evidence linking ovarian cancer to talcum powder is strong enough to warrant a recall of all J&J powder products.
Saturday, June 18, 2016 - A talcum powder cancer lawyer has called for Johnson & Johnson to remove its baby powder products from stores. The complaint came in a television interview in the wake of massive awards divided in favor of plaintiffs in recent Johnson & Johnson's baby powder judgments. The talcum powder cancer lawyer claims that the baby powder products have been medically linked to an increased risk in ovarian cancer, and that Johnson & Johnson are putting their customers at risk by continuing to offer the products without proper warning labels informing the public of the potential consequences.
The talcum powder attorney, Ted Meadows, was one of the lawyers representing Gloria Ristesund in a recent baby powder ovarian cancer lawsuit. Ristesund sued Johnson & Johnson for failing to warn consumers of the ovarian cancer risk its talcum powder products posed, claiming that the company had known of the cancerous links for years. The first talcum powder study that looked into a connection between the product and ovarian cancer was conducted in 1971, and more than 20 have been conducted since then that have overwhelmingly found evidence supporting the notion that talcum powder can increase a woman's chance of contracting ovarian cancer when used genitally. Ristesund was awarded $55 million by a jury in May before the City of St. Louis Circuit Court.
Meadows has fought against Johnson & Johnson along with talcum powder lawyers around the country that believe their clients may not have contracted ovarian cancer if Johnson & Johnson would have included adequate warnings to their baby powder products. He claimed that evidence has existed constituting a risk that necessitated a warning since 1982. There have also been internal documents unearthed from Johnson & Johnson that prove the company has been aware of the problem since the early 90's. Plaintiffs have claimed that Johnson & Johnson kept this information from consumers so they wouldn't risk the marketability of one of the company's flagship products. Johnson & Johnson baby powder is used as a cosmetic worldwide, and the reaction to the recent talcum powder cancer lawsuits filed in the U.S. have come from the international community.
India's food and drug administration began testing baby powder samples, while Qatar imposed a temporary ban on the cosmetic when news of the pair of talcum powder lawsuit awards was first announced. In addition to Ristesund's $55 million award in May, $72 million was awarded to a talcum powder cancer lawsuit plaintiff in February. Both of these cases were heard before the City of St. Louis and made news worldwide. The next Johnson & Johnson's baby powder lawsuit to be heard before the court will take place in September.
The amount of potential plaintiffs that could amass in the U.S. and internationally is vast, as Meadows claims that experts have estimated 10 percent of all ovarian cancer diagnoses in the U.S. can be attributed to talcum powder use. The call to take the product off shelves will more than likely fall on deaf ears for the time being, but there is no doubt that Johnson & Johnson is listening to the complaints contained in the more than 1,000 baby powder lawsuits that have already been filed against the company.
OnderLaw, LLC -